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ABSTRACT 
Background: Therapeutic misunderstanding (TMU) and its three facets: 
therapeutic misconception, therapeutic misestimation, and therapeutic optimism 
have been identified as major challenges to the ethical conduct of clinical 
research and obtaining informed consent from research participants. However, 
the prevalence of TMU among clinicians and researchers has not been explored. 
Since most physicians will be exposed to clinical research over the course of 
their career, the understanding of clinical research procedures is important. In 
this study we attempted to determine the prevalence of TMU among medical 
students: future clinicians. 
Methods: Twenty-two BUSM undergraduate medical students took part in a two-
part, survey evaluating the prevalence of therapeutic misunderstanding using 
“The Therapeutic Misunderstanding Scale”. The attitudes of the students towards 
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increasing the exposure to clinical research topics through the medical school 
curriculum were also determined. 
Results: The majority of the medical students exhibited therapeutic 
misunderstanding, particularly in the area of therapeutic misconception. In 
particular, the misunderstanding the difference between evidence-based clinical 
care versus hypothesis driven clinical research was exhibited. Although there 
was strong agreement that education in clinical research and clinical research 
ethics was important, the participants though increases of clinical research topics 
in the curriculum was not needed.  
Conclusions: The increased prevalence of TMU among future physicians 
underscores the need to teach clinical research and research ethics. Further 
research on a larger sample needed to validate the findings. 
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1.0 BACKGROUND 
 Over the course of their careers, almost every clinician will have a role in 
balancing both clinical care of their patients as well as clinical research. 
Regardless of direct participation in research by a clinician, a general 
understanding of the basic principles, both functional and ethical, of clinical 
research is needed. Every clinician must read and interpret the biomedical 
literature in order to practice evidence based medicine. Many clinicians will have 
to answer questions from their patients concerning participation in clinical 
research studies. With an ever increasing number of clinical trials, and 
advertisements on TV, in newspapers, and on the internet, it is almost certain 
that clinical research will make its way into every clinical practice at some point.1,2 
For clinicians who will not go through formal training in clinical research, the 
basic functional and ethical issues must be covered somewhere in their medical 
education. Because advising patients on research participation is an important 
part of the physician-patient relationship, improvements to undergraduate 
medical curricula need to be made, and this has been recognized by the medical 
students themselves.3,4 
 The goal of clinical research and clinical research ethics education should 
be to educate medical students in the fundamentals and major ethical issues 
they will face when conducting or advising on participation in clinical research, as 
well as reading and interpreting the biomedical literature or performing the 
informed consent process. The differences between clinical care and clinical 
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research, clinical equipoise, clinician/researcher duality of role, and the general 
all-encompassing misunderstanding of clinical research among research 
participants, are concepts about which every clinician must have a general 
understanding. Beginning in 1982, misunderstanding of these concepts in 
research participants as well as clinicians is what has been termed therapeutic 
misconception.5 This term has undergone some revision and much controversy 
over the last 30 years. Therapeutic misconception has come to be recognized as 
just one of three facets of the greater construct, therapeutic misunderstanding.6 
 
1.1 Therapeutic Misunderstanding 
Clinical Care versus Clinical Research 
 Clinical care is the evidence-based, individualized care of a patient by 
their physician. It encompasses the whole of diagnostic procedures and 
treatments with the sole goal of maintaining or improving the health of the current 
patient whereas clinical research is hypothesis-based process, mostly (with some 
exceptions) geared towards generating newer data, and helping future patients.1 
 
Clinical equipoise 
 Clinical equipoise is a basic concept in clinical research ethics. Equipoise 
is defined as “the genuine uncertainty about the risks and benefits of the test 
treatment. That is, there must be sufficient certainty that the test treatment might 
be beneficial in order to administer it to some individuals while, at the same time, 
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sufficient doubt about its benefits in order to withhold it from others.”7 It is this 
concept that provides us with the ethical footing to randomly assign research 
participants to separate treatment groups. These groups usually comprise a 
group receiving the treatment/intervention under study, and a comparison group 
that may be a placebo, standard of care, or sham device/surgery. Clinical 
equipoise is where ethically, we can make the greatest distinction between 
clinical research and clinical therapy.  In clinical research the goal is to answer a 
specific scientific question to add to “generalizable knowledge” about a condition 
and its treatment through experimentation.  
 
Clinician/Researcher Duality of Role 
 Increasingly in the United States, and elsewhere, industry based clinical 
research is moving away from the academic medical center model and a much 
higher number of clinical trials are moving into the private practices of active 
clinicians.8,14 
  Between 1980 and 2004 the percentage of clinical trial sites based in 
academic medical centers decreased from 80% to 30%.9 Since 1990 the number 
of private practice based clinicians conducting clinical trials has increased from 
4,000 to over 20,000.1,9  In 2008, clinical trial spending broke $11 billion, and as 
much as 36% of that spending was in private practice-based trials.10 A recent 
study of private practice based physicians identified one of the major reasons for 
this shift is the financial incentives: “We’re paid less and less for the work we do. 
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In fact, we’re paid about 50% of what we made 20 years ago…So one of the 
ways we offset that [trend] is to find an alternative source of revenue, and getting 
into research was a way to do that.” 9  With the rising costs of healthcare for both 
patients and clinicians, the role of the financial interests that come along with 
participation in clinical research studies by clinicians provides increasing conflicts 
within the doctor-patient relationship.9  
 In both private practice and academic medical/research centers, this 
“duality of role” and the inherent differences and goals of the clinician versus the 
researcher must be fully understood by research subjects for them to give 
complete informed consent. In the setting of a dedicated research clinic, this 
difference is easier to show. A dedicated clinical researcher is not a research 
subject’s regular primary care physician or specialist and is not regularly 
recommending or prescribing treatment for the research subject in an ongoing 
manner. It is easier for the research subject to see the temporary relationship 
(the instances where a researcher may see the research subject in another 
setting such as a separate clinic setting at the same institution is a separate case 
that falls under the following example).  
 Outside of the dual role of the clinician/researcher is the potential of a 
clinician helping their patient make decisions about participating in clinical 
research. This could come from referring their patients to a research study 
because of lack of treatment options, or to answer questions about the risk 
versus benefits of participating in a research study conducted elsewhere. A 
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potential research subject’s regular clinician(s) is more poised than the 
researcher to understand the broad implications of a particular research 
intervention on the subject’s health. Most importantly, how participating in the 
study may adversely affect their health, from interactions of medications, 
necessary changes to their current therapy, or the multitude of tests, blood work 
and questionnaires that go along with the data collection of research, many of 
which may have risks beyond that of the particular intervention itself. The 
subject’s clinician can also provide a more unbiased view of the research study 
than that of the researcher, who even though well-intentioned has financial 
conflicts and recruitments deadlines.
1,11,12
 
  The misunderstanding of the dual role of the clinician/researcher, the 
general misunderstanding of differences between clinical care and clinical 
research and the effects these issues have on informed consent has been 
labeled therapeutic misconception when it exists in research subjects. 
 
Therapeutic Misunderstanding and Therapeutic Misconception 
Therapeutic misconception (TM) was first described in by Appelbaum et 
al. in 1982 as the assumption of research subjects that “decisions about their 
care are being made solely with their benefit in mind” in relation to the subjects’ 
participation in research activities. Appelbaum anecdotally expressed this in the 
following back and forth between a researcher and their subject: 
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Gray: “How did you think they were going to decide which drug to 
give you? Did you know?” 
 
Subject: “Well, I figured they would take into consideration, you 
know, my condition and what was happening to me.” 
 
Gray: “That’s what I was wondering, because several people told 
me they figured they would get the best drug for them.” 
 
Subject: “Yeah. I certainly thought I was taken into consideration.” 
 
demonstrating the therapeutic misconception, in this case the lack of under-
standing of randomization and blinding in the study participated in.5 
 In 2007, Jonathan Kimmelman discussed TM at 25.13 Kimmelman defined 
TM as “the failure of research subjects to appreciate the ways that study 
procedures interfere with individualized care.” Kimmelman notes the growing 
acknowledgement of TM as a research ethics issue, especially since 2000, 
highlighting the increasing number of publications in PubMed referencing TM, as 
well as the number of articles citing Appelbaum 1987 on TM, where the concept 
was brought to a larger audience.  
Despite its 30-year existence in the medical terminology the exact nature 
of TM is still debated and some have proposed that it is really one of three facets 
of a greater subject, Therapeutic misunderstanding (TMU) which also covers 
Therapeutic misestimation (TE), and Therapeutic optimism (TO).6 The concept of 
TM was relegated to the simple conflation of research with clinical care while TE 
is described as the underestimation of risk to the research subject and/or the 
overestimation of the benefit to the subject. TO on the other hand is a more 
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emotional response wherein the research subject “hopes for the best personal 
outcome.” TM and TE together are seen as the greater threat to the informed 
consent process in research. It is with these two concepts that research subjects 
really misunderstand the differences between research and clinical care or 
therapy. TO, on the other hand, is much less of a misunderstanding than an 
emotional response, ‘hope’ that they will have improvement in their condition. As 
Horng and Grady suggest, “An optimistic outlook likely makes a positive 
contribution to the healing process.” TO alone does not constitute the greater 
TMU, however it can magnify the effects of TM and TE.6 
Henderson et al. postulate a different definition of therapeutic 
misconception, focusing solely on the understanding of clinical care versus 
research. That the purpose of research is to gain generalizable knowledge and 
any potential therapeutic benefit is merely a secondary concern.14 Henderson 
goes on to list 5 dimensions that research participants should understand for true 
informed consent: scientific purpose of the research, study procedures, 
uncertainty (equipoise), adherence to the protocol, and clinician as investigator 
(duality of role). 
Miller explains that therapeutic misconception is not limited to research 
subjects but also applies to clinicians and clinician-researchers.15 Various 
authors have estimated that TM among clinicians may be as high as 60%, 
however the reasons or area of TM are not always the same for researchers and 
research subjects.12,16 If researchers conflate the ethics of clinical research with 
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the ethics of therapeutic medicine, they may implicitly “foster the therapeutic 
misconception among their research participants.”15 This has been termed 
“Therapeutic Misdirection” and may be unintentional. It is especially concerning 
when although well-intentioned, researchers attempt to personalize care of 
research subjects.17,18 Green’s analysis of IRB exception requests, requests to 
deviate from the study protocol,  showed the most frequently given reason was to 
enable the research subject to receive the treatment instead of being randomized 
to treatment or placebo, or for subjects who did not meet inclusion/exclusion 
criteria.18  
 
The Therapeutic Misunderstanding Scale 
 The Therapeutic Misunderstanding Scale (TMU scale) was developed and 
validated by Chou and O’Rourke in response to the need for an instrument of 
sufficient breadth to evaluate TMU, but without being overly long and too 
unwieldy to be widely utilized. The TMU scale was designed using psychometric 
procedures unlike previous scales developed by Appelbaum et al.19 However, 
“The Therapeutic Misconception Scale”, a 6-item T/F instrument from Dunn and 
Appelbaum was the starting point for question content and survey design. The 
original Therapeutic Misconception Scale was scored 0 to 6 with a full score of 6 
required to show no TM. After the presence of TM is determined, the specific 
questions answered incorrectly can be evaluated for areas where focus in 
informed consent can be improved.20  
  9 
 The validation population for the TMU scale was an older, computer 
literate, Canadian and American population, mean age 59.8 years, well 
educated, mean 13.9 years of formal education, exclusively with internet data 
collection techniques. The study was in two parts, generating the useable items 
from a larger pool using psychometric methodology, and then validation by 
analog methodology using a defined hypothetical clinical trial situation. The study 
participant population consisted of individuals who had previously participated in 
randomized clinical trials as well as those who never had participated in 
research. Chou et al. note that analog methodology is useful because it allows 
participants to respond based on their perceptions of the hypothetical situation 
rather than their past experiences.19 
The Therapeutic Misunderstanding Scale itself consists of 20 items that 
can be administered with short Likert-type scales or with a briefer True or False 
answer. (See Appendix B)  Each individual item covers concepts related to the 
three-facet TMU construct of Horng and Grady, TM (9), TE (6), and TO (5).  
These concepts range from understanding the differences between clinical care 
and clinical research, clinical equipoise, and the differences between a practicing 
clinician and a research clinician. Ultimately, it can be used to judge the 
effectiveness of the informed consent process outside of the clinical specifics of 
the intervention and its risks in a particular study, and the general understanding 
of the research participant.  
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Responses can be averaged or summed, depending on if utilized with a 
likert scale or binary true or false response respectively, in total to yield a raw 
score that can be linked to a certain degree of Therapeutic Misunderstanding, or 
average per item scores can be analyzed against a variety of demographic or 
life/educational experience information collected to show areas of greatest 
misunderstanding.  
 The TMU scale was designed to be used with research subjects, 
administered at some point after informed consent was obtained for participation 
in a clinical trial. Subjects would answer the questions based on reading the 
hypothetical scenario presented at the beginning of the survey, and the survey 
would be scored based on the generalized structure of a randomized clinical trial 
(RCT) and choosing the best answer. The basic structure of a randomized, 
double blind, placebo controlled study is designed around a strict protocol for 
generalizable results, not individual benefit, which cannot be guaranteed. 
Adjustments to the study drug, and individualized treatments are not allowed in 
the general RCT study design.   
 
1.2 Clinical Research and Clinical Research Ethics in Undergraduate 
Medical Education  
 A 2000 survey of U.S. and Canadian medical schools showed that 70% of 
schools allotted 20 or more hours of ethics instruction in their curricula. The 
largest focus of instruction was in clinical situations (informed consent, health 
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care proxy etc.) at 96% of responding schools. Research ethics topics were only 
reported to be part of the curricula at 54% of the schools, and the role of ethics 
committees, was discussed in only 42% of curricula.21  
 At BUSM formal instruction in clinical research and research ethics topics 
such as TM takes place early in the first year in the “Evidence-based Medicine” 
course, covering approximately 12 instructional hours. Medical and research 
ethics related topics are taught through the “Essentials in Public Health” course 
and have also been integrated in to the general curriculum. It is expected that 
these topics will also be learned through clinical rotations, discussions with 
mentors, journal clubs as well as integrated into applicable didactic lectures. 
 Roberts et al over the last decade have conducted numerous cross-
sectional surveys as well as interventional studies at the Universities of New 
Mexico and Wisconsin exploring ethics curricula, and medical students’ 
expectations regarding the curricula with a later focus on clinical research topics 
and education. Their studies have shown positive attitudes among the students 
about the need for increased education in clinical research related topics as well 
as improved ethical reasoning in medical students who are taught to recognize 
ethical delemas.3,4,22 A 2004 cohort study followed undergraduate medical 
students through their education, asking about a broad range of medical ethics 
topics and mapping changes in those attitudes over a three year period.  Most 
criteria measured, including those on ethical topics, showed a general decrease 
in positive attitudes over a student’s time in school. It was agreed in general, that 
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subject matter in these areas was seen as less important than basic and clinical 
sciences and skills.23 In a 2001, 3-arm, interventional study of medical students, 
it was shown that students who were taught to use the Research Protocol Ethics 
Assessment Tool or who viewed a presentation on personal perspectives and 
experiences of seriously ill individuals who participated in research studies were 
better able to answer questions about ethical dilemmas’ than the control group 
who answered the same questionnaire without any ethics instruction.22 
 Students entering undergraduate medical education have a preexisting 
perception of healthcare and the practice of clinical medicine.  These preexisting 
perceptions are derived from their life experiences and may include influences 
from medical histories related to their personal lives, as well as previous 
educational and research exposures. It has been shown in numerous studies that 
women demonstrate a greater perception of the need for ethics education, as 
well as a decrease in this perception among all groups as the students progress 
through medical school.3,4,22,23 As Woloschuk discussed, these attitudes can be 
overshadowed by more discrete science and clinical portions of the education. 
There is also a loss of the higher idealism that students may enter medical 
school with, replaced with a more realistic view of medical practice and a general 
desire to finish school and get out into the real world. This needs to be 
considered in the design and temporal positioning of coursework over the course 
of medical school.23  
  13 
 Focus groups with medical students who conducted undergraduate 
research, both basic and clinical, have shown that students are aware of 
research and its importance. However, students are not always clear what 
constitutes various forms of research, or how it differs from clinical care in the 
case of clinical research, leading to therapeutic misunderstanding among 
students and clinicians. Students also came out of undergraduate research with 
more of a feeling of “hired help” as opposed to active researchers.2 These 
experiences can augment the preconceived notions of research, which could in 
turn affect their willingness to address research and research ethics-related 
topics, making formalized training in research and research ethics related topics 
essential. Murdoch-Eaton states, that “All clinicians need to understand research 
and the research process, even if they are not actively engaged in research 
itself.2 Evidence-based medicine requires clinicians to make informed judgments 
on the best possible care for their patients or populations, and base this upon the 
best available evidence.” Thus it is not only important for a clinician to have a 
good foundation in the basic science and clinical skills, but a thorough 
understanding of the biomedical literature, which can only come from 
understanding the underlying research, and  ethical principles that govern how 
and why research is conducted. 
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Attitudes Towards Clinical Research Ethics education Survey 
 The Attitudes Towards Clinical Research Education survey (Attitudes) is a 
12 item questionnaire assessing the interests of ethics education among medical 
students, with a focus on clinical research topics. (See Appendix C) Questions 
were adapted from surveys developed by Roberts et al., as well as questions 
developed for the purposes of this survey. The survey consists of 24 major items 
in 12 groups scaled on a 9 point Likert-type scale, 1= strongly disagree, 9= 
strongly agree.  Individual item means can be compared across a variety of 
demographic or life/educational experiences collected as part of the 
demographics and predictor variable questionnaire. In addition several items 
evaluate attitudes towards similar clinical versus research related concepts.  
 Previous studies by Roberts et al and Woloschuk et al have shown that 
there is moderate to high agreement towards the need for increased ethics 
training in the undergraduate medical curriculum.3,4,22,23,24 
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2.0 METHODS AND MATERIALS 
 This was a two-part, survey-based, cross-sectional pilot study of 
undergraduate medical students at Boston University School of Medicine in the 
2012-2013 academic year. 
 
2.1 Study Hypotheses 
Hypothesis 1 
 A majority of BUSM undergraduate medical students will demonstrate 
therapeutic misunderstanding, as defined by a score of ≤14 on The Therapeutic 
Misunderstanding Scale. 
 
Hypothesis 2 
 A majority of BUSM undergraduate medical students will agree with a 
mean score of ≥7 that clinical research and clinical research ethics education is 
important (question 12 on the Attitudes Towards Clinical Research Ethics 
Education Survey). 
 
Hypothesis 3 
 A majority of BUSM undergraduate medical students will agree with a 
mean score of ≥7 that there should be increased focus on clinical research and 
clinical research ethics education in the medical school curricula (question 13 on 
the Attitudes Towards Clinical Research Ethics Education Survey). 
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2.2 Study Population 
 The eligible population consisted of all undergraduate medical students, 
BUSM I through BUSM IV, including dual degree students currently in their PhD 
or master’s degree year. There were approximately 730 students enrolled during 
the 2012-2013 academic year. For the pilot study, it was intended to recruit up to 
50 undergraduate medical students: 25 BUSM I and II’s, and 25 BUSM III and 
IV’s. Dual degree students currently in their PhD, MPH, or Masters year were 
included in the BUSM III and IV cohort (post-didactic).  
 
2.3 Study Surveys 
 The study surveys consisted of two parts: The Therapeutic 
Misunderstanding Scale (See Appendix B) and the Attitudes Towards Clinical 
Research Education Survey. (See Appendix C) In addition, a short demographic 
and personal history questionnaire was included as part of the Attitudes survey. 
The surveys were completed anonymously. No identifying information was 
collected. The surveys included an institutional review board-approved cover 
letter to serve as assent to participate in the study in place of a signed informed 
consent form. 
 
The Therapeutic Misunderstanding Scale 
 The Therapeutic Misunderstanding Scale consists of 20 items in one of 
three facets, therapeutic misconception, therapeutic misestimation, or therapeutic 
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optimism. For this study, the questions administered with true or false responses. 
Six sham questions were added to the survey to help negate the bias towards 
the false in the responses. This was done in correspondence with Chou and 
O’Rourke who designed the TMU scale. 
 For Hypothesis 1, only the responses to the therapeutic misconception 
and therapeutic misestimation questions were scored. Questions pertaining to 
the therapeutic optimism facet were analyzed for exploratory purposes only. In 
accordance with previous studies with similar scales, a single incorrect response 
was deemed to show therapeutic misunderstanding. Individual items were then 
examined for specific areas of therapeutic misunderstanding. 
 
The Attitudes Towards Clinical Research Ethics Education Survey 
 The Attitudes Towards Clinical Research Ethics Education Survey is a 24 
item questionnaire arranged in 12 questions, assessing the interests of ethics 
and research ethics education among medical students. Questions for this short 
survey were adapted from surveys developed by Roberts et al. and questions 
developed for the purposes of this pilot study. Survey items were answered on a 
9 point Likert-type scale, 1= strongly disagree, 9= strongly agree. 
 
Demographics and Personal History Questionnaire 
 A short demographics questionnaire was administered with the Attitudes 
survey. This questionnaire included questions concerning the educational, and 
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employment (or volunteer) history in areas that relate to clinical care or research 
related activities. 
 
2.4 Institutional Review Board Approval 
 The study protocol was submitted to the Boston University Medical Center 
Institutional Review Board (IRB) for review. The study was approved by the IRB 
on March 26, 2013. 
 
2.5 Study Recruitment and Data Collection 
 Study participants were recruited through use of flyers, electronic display 
boards, school-wide electronic newsletters and participant referral. Two group 
administrations of the study surveys were undertaken approximately 2 weeks 
apart. 
 A total of 22 participants were recruited between the two recruitment 
events. 
 Study participants were given instructions to answer all the questions. 
They were also instructed to choose “the best” answer to questions on the TMU 
Scale, and to not overthink their responses.  
 
2.6 Data Entry and Quality Control 
 The TMU Scale was scored by the principal investigator and the scoring 
was reviewed by a research assistant. 
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 The responses to the surveys and questionnaire were then entered into 
two prepared excel spreadsheets by the principal investigator, and by a research 
assistant. The two spreadsheets were then merged and checked for 
discrepancies between the two entries. A final spreadsheet was prepared and 
locked from editing for use with a statistical analysis package. 
 
2.7 Statistical Analysis Plan 
Data were described using means, standard deviations, and ranges for 
overall scores and using counts and proportions for individual items. For 
analyses of association, a subject’s expressing therapeutic misunderstanding 
was indicated by an individual score of 14 or less (the greatest possible score is 
15). Prevalence and odds ratios were calculated for presence of therapeutic 
misunderstanding where possible. The association of items scores of the TMU 
with demographic and predictor variables were analyzed by chi-square tests and 
Fisher’s exact tests. Multiple logistic regressions were not performed as planned 
due to inability to calculate odds ratios for all items resulting from small sample 
size.  Responses to attitude items were rated on a 9-point Likert type scale 
(treated as a continuous outcome), and were analyzed by Students t-tests, and 
ANOVA. Due to small sample size, general trends were explored through 
descriptive statistics. 
  
  20 
3.0 RESULTS 
3.1 Study Sample 
 A total of 22 students participated in the pilot study and made up the study 
sample. (See Tables 1.1 and 1.2, Demographic Characteristics and Primary 
Outcomes)  
 The study sample was split evenly between men (n=11) and women 
(n=11). Fourteen participants were aged ≤ 24 (64%), 7 were aged 25-29 (32%), 
and 1 was aged ≥30 (5%). Twenty (91%) were either BUSM I or II, and 2 (9%) 
were BUSM III or IV or in their dual degree year. Seven (33%) intended to pursue 
primary care as their specialty, 14 (67%) intended to pursue surgery or other 
specialties, no participants anticipated pursuing psychiatry as their specialty.  
 Four participants (18%) had previously completed graduate degrees, and 
8 (36%) had previous clinical experience  
 Twenty one participants (95%) had previous research experience; of 
which 13 (63%) had basic or “bench” research experience, 7 (34%) had research 
experience involving animals, and 12 (58%) had clinical research experience. 
Eight (36%) participants anticipated research as part of their future medical 
career; of which 2 (9%) planned on basic or bench research, 1 (5%) planned on 
animal research, and 6 (27%) planned on being involved in clinical research. 
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TABLE 1.1 
n (%) Total Gender TMU
Male Female Yes No ≥7 <7 ≥7 <7
Gender (%)
Male 11 (50) 11 (100) 0 (0) 10 (91) 1 (9) 7 (64) 4 (36)
Female 11 (50) 10 (91) 1 (9) 9 (82) 2 (18) 6 (55) 5 (45)
TMU (%)
Yes 21 (95) 11 (52) 10 (48) 18 (86) 3 (14) 13 (62) 8 (38)
No 1 (5) 0 (0) 1 (100) 1 (100) 0 (0) 0 (0) 1 (100)
Age (%)
≤24 14 (64) 6 (43) 8 (57) 14 (100) 0 (0) 13 (93) 1 (7) 9 (64) 5 (36)
25-29 7 (32) 4 (57) 3 (43) 6 (86) 1 (14) 5 (71) 2 (29) 3 (43) 4 (57)
≥30 1 (5) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 0 (0)
BUSM Year (%)
I or II 20 (91) 9 (45) 11 (55) 19 (95) 1 (5) 17 (85) 3 (15) 11 (55) 9 (45)
III or IV 2 (9) 2 (100) 0 (0) 2 (100) 0 (0) 2 (100) 0 (0) 2 (100) 0 (0)
Anticipated Specialty (%)
(n=21)
Primary Care 7 (33) 2 (29) 5(71) 7 (100) 0 (0) 6 (86) 1 (14) 4 (57) 3 (43)
Other/ 14 (67) 9 (64) 5 (36) 13 (93) 1 (7) 13 (93) 1 (7) 9 (64) 5 (36)
Surgery
Graduate Degree (%)
Yes 4 (18) 4 (100) 0 (0) 4 (100) 0 (0) 4 (100) 0 (0) 3 (75) 1 (25)
No 18 (22) 7 (39) 11 (61) 17 (94) 1 (6) 15 (83) 3 (17) 10 (55) 8 (45)
 
Previous Research Exp. (%)
Bench 13 (63) 5 (38) 8 (62) 12 (92) 1 (8) 12 (92) 1 (8) 8 (62) 5 (38)
Animal 7 (34) 2 (29) 5 (71) 7 (100) 0 (0) 6 (86) 1 (14) 4 (57) 3 (43)
Clinical 12 (58) 8 (67) 4 (33) 12 (100) 0 (0) 11 (92) 1 (8) 9 (75) 3 (25)
None 1 (5) 1 (100) 0(0) 1 (100) 0(0) 1 (100) 0(0) 0 (0) 1 (100)
DEMOGRAPHIC CHARACTERISTICS AND PRIMARY OUTCOMES (n=22)Importance of 
Clinical 
Research and 
Ethics 
Education
Increase Focus 
on Clicnial 
Research and 
Ethics
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TABLE 1.2 
n (%) Total Gender TMU
Male Female Yes No ≥7 <7 ≥7 <7
Future Research Career? (%)
Bench 2 (9) 1 (50) 1 (50) 2 (100) 0 (0) 2 (100) 0 (0) 2 (100) 0 (0)
Animal 1 (5) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 0 (0) 1 (100) 0 (0)
Clinical 6 (27) 2 (33) 4 (67) 5 (83) 1 (17) 6 (100) 0 (0) 5 (83) 1 (17)
None 14 (64) 8 (57) 6 (43) 14 (100) 0 (0) 11 (79) 3 (21) 6 (43) 8 (57)
RCT Participation? (%)
Yes 2 (9) 1 (50) 1 (50) 2 (100) 0 (0) 1 (50) 1 (50) 1 (50) 1 (50)
No 20 (91) 10 (50) 10 (50) 19 (95) 1 (5) 18 (90) 2 (10) 12 (60) 8 (40)
Yes 8 (36) 3 (38) 5 (63) 8 (100) 0 (0) 8 (100) 0 (0) 6 (75) 2 (25)
No 14 (64) 8 (57) 6 (43) 13 (93) 1 (7) 11 (79) 3 (21) 7 (50) 7 (50)
Informed Consent? (%)
(n=8)
Yes 2 (25) 0 (0) 2 (100) 2 (100) 0 (0) 2 (100) 0 (0) 1 (50) 1 (50)
No 6 (75) 3 (50) 3 (50) 6 (100) 0 (0) 6 (100) 0(0) 5 (83) 1 (17)
Medical Ethics Course? (%)
Yes 9 (41) 5 (56) 4 (44) 8 (89) 1 (11) 8 (89) 1 (11) 5 (55) 4 (45)
No 13 (59) 6 (46) 7 (54) 13 (100) 0 (0) 11 (85) 2 (15) 8 (62) 5 (38)
Other Ethics Course? (%)
Yes 12 (55) 5 (42) 7 (58) 11 (91) 1 (8) 11 (92) 1 (8) 7 (58) 5 (42)
No 10 (45) 6 (60) 4 (40) 10 (100) 0 (0) 8 (80) 2 (20) 6 (60) 4 (40)
Yes 21 (95) 11 (52) 10 (48) 21 (100) 0 (0) 18 (86) 3 (14) 13 (62) 8 (38)
No 1 (5) 0 (0) 1 (100) 0 (0) 1 (100) 1 (100) 0 (0) 0 (0) 1 (100)
DEMOGRAPHIC CHARACTERISTICS AND PRIMARY OUTCOMES CONTINUED (n=22)
Previous Clinical Exp. (%)
Difference Between Clinical and Non 
Clinical Research? (%)
Importance of 
Clinical 
Research and 
Ethics 
Education
Increase Focus 
on Clicnial 
Research and 
Ethics
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 Two participants (9%) had participated or had had a close relative who 
had participated in a RCT. Nine (41%) had taken a medical ethics course prior to 
enrolling in medical school, and 12 (55%) had taken another type of course in 
ethics. Twenty-one participants (95%) indicated they understood the difference 
between clinical and non-clinical research. 
 
3.2 Prevalence of Therapeutic Misunderstanding among the BUSM 
Undergraduate Medical Student  
 Of the 22 participants who completed the TMU Scale, 21 (95%) exhibited 
some level of Therapeutic Misconception. One participant, female, aged 24-29, 
BUSM I or II, no previous graduate degree, previous basic or “bench” research 
but anticipating a career involving clinical research responded correctly to all 
items of the TMU scale. This student also had not participated in a RCT in the 
past, had previous clinical experience without informed consent experience, and 
had previously taken both a medical ethics course and other ethics courses. This 
student also highly agreed that education in clinical research and clinical 
research ethics is important (≥7 on 9 item Likert scale, 9= strongly agree), but did 
not highly agree with the need for increased focus on clinical research or clinical 
research ethics education in the medical school curricula. (See Tables 1.1 and 
1.2, Demographic Characteristics and Primary Outcomes)  Of the remaining 
participants, 4 (18%) answered only 1 survey item incorrectly, and 3 (14%) 
answered only 2 survey items incorrectly. One (5%) participant scored a total of 
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five correct responses; otherwise the next lowest score was 10/15. (See Figure 
1) 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The number of correct responses to The Therapeutic 
Misunderstanding Scale (Therapeutic Misconception and Therapeutic 
Misestimation) by question number. Omitted questions were non-scored 
Therapeutic Optimism and filler questions. 
 
 The most commonly correct answered item was #21, “My participation in 
this clinical trial will prolong my life.” with all 22 participants answering “false” 
correctly. Three items, #4, #12, and #13 received 21/22 correct responses and 2 
items, #10 and #16 received 20/22 correct responses. The most commonly 
incorrect item was item #23, “This trial is conducted mostly to gather knowledge 
about my condition.” The answer is false; the trial is conducted to gather 
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knowledge about the intervention, though this is the one of the most ambiguous 
questions in the survey.  
 
Therapeutic Misconception 
 Nearly all the incorrect responses to the TMU Scale were in the TM 
questions, 1, 5, 7, 9, 12, 17, 19, 23, and 26. 
 Study participants were able to correctly respond to questions regarding 
clinical equipoise, such as questions 9 (86%) Medical researchers are only 
allowed to do things that would benefit all patients, and question 5 (82%) The 
researchers in this study know that one of the treatments or interventions in this 
study will have better results than the others. 
 Responses to questions regarding the physician/researcher duality of role, 
and the differences between researchers and practicing clinicians were mixed. 
Question 19 was answered correctly by only 11 (50%) of the participants; My 
doctor could access the information obtained during the course of this study, but 
question 17 was answered correctly by 17 (77%); My doctor would adjust the 
treatment I receive (e.g. medication dosage) to ensure that I receive the best 
possible care. 
 Questions regarding the differences between clinical care and clinical 
research posed the most difficulty with the study participants. Question 26 was 
answered correctly by 10 (45%) of the participants; The treatment/intervention I 
would receive may be changed in response to the way my medical condition 
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changes, and question 23 was answered correctly by 8 (36%) of the participants; 
This trial is being conducted to mostly gather knowledge about my condition. 
However, nearly all the participants, 21 of 22 (95%) responded correctly to 
question 12; The treatment I would receive is based on my medical needs. 
 
Therapeutic Misestimation 
 The TE questions included questions 4,10,13,16,21, and 22. All of the 
study participants answered most of these questions correctly, not 
overestimating the potential benefits, or lack thereof of participating in a RCT. 
Question 21 was answered correctly by all the study participants, while questions 
4 and 13 were answered by 21 of 22 (95%) participants correctly. Questions 10 
and 16 were answered by 20 of 22 participants correctly (91%) and question 22 
was answered correctly by 19 0f 22 participants (86%). 
 
Therapeutic Optimism 
 Survey participants showed generally positive optimism towards their 
previous experiences preparing them to take part in a research study (73%), and 
the majority of the participants looked forward to participation (68%), and 
expressed hope and enthusiasm (73%). 
 The survey participants showed no optimism (or indifference) to the 
chances for successful treatment (14% optimistic), or that participating would 
help them (36% optimistic).   
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3.3 Attitudes Towards Clinical Research and Clinical Research Education  
Refer to tables 1.1 and 1.2 pages 21-22, and tables 3.1-3.6 in appendix D. All 
means are based on responses to a 9 point likert type scale (1= strongly 
disagree, 5 = neither agree nor disagree, 9 = strongly agree). 
 
Importance of Clinical Research and Research Ethics Education 
 Of the 22 participants in the study, 19 (86%) highly agreed with a score ≥7 
that clinical research and research ethics education is important. Overall, Study 
participants highly agreed that clinical research and research ethics is important 
with a mean of 7.95 (SD 1.0, range 6-9).  
 
Attitudes to Increased Focus on Clinical Research and Research Ethics in the 
Medical School Curriculum 
 Of the 22 participants in the study, 13 (59%) highly agreed with a score ≥7 
that there should be increased focus on clinical research and research ethics. 
Study participants overall only mildly agreed that there should be increased focus 
on research related topics, mean 6.72 (SD 1.6, range 2-9). 
 
Attitudes Towards Clinical Medicine versus Clinical Research Goals of Ethics 
Education  
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 Study participants highly agreed in interest in learning about ethics in 
clinical medicine, mean 7.78 (SD 1.1, range 5-9), but only mildly agreed that 
there is an interest in learning about ethics in clinical research, mean 6.95 (SD 
1.3, range 5-9). In terms of ethics education the highest agreement was that the 
goal of ethics education is to help professionals to improve patient care and 
clinical decision making, mean 8.00 (SD 1.5, range 2-9), while they least agreed 
that the goal of ethics education is to acquire a working knowledge of social 
science, philosophy, religion and law as they apply to clinical research, mean 
6.55 (SD 2.3, range 2-9). 
 Study participants highly agreed that both ethics in clinical medicine, mean 
8.14 (SD 1.2, range 5-9), and ethics in clinical research, mean 7.32 (SD 1.3, 
range 4-9), should be formally taught in medical training. They also highly agreed 
equally that ethics training helps physicians, mean 7.59 (SD 1.2, range 5-9), and 
helps researchers, mean 7.59 (SD 1.1, range 5-9). 
 The study participants highly agreed that ethics can be taught and 
learned, mean 7.27 (SD 1.5, range 4-9), but only had mild agreement in the need 
for researchers to have more ethics training than is already provided, mean 6.41 
(SD 1.8, range 2-9). The study participants most highly agreed that ethics 
training should take place in journal clubs and seminars, mean 7.95 (SD 1.8, 
range 2-9), versus during formal didactic (classroom) training, mean 6.64 (SD 
1.7, range 2-8) or post didactic training (clerkship) training, mean 6.95 (SD 1.8, 
range 2-9) 
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 Unlike previous studies, no major trends were seen among the various 
participant characteristics. Age, sex and BUSM year showed no observable 
trends in responses between matched clinical medicine and clinical research 
questions. Other areas that were thought to affect attitudes towards ethics 
education such as prior clinical or research experience, anticipation of a research 
career, history of participation in a RCT or previous medical ethics or other ethics 
coursework also showed no consistent trends towards difference in responses to 
the attitudes survey questions. 
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4.0 DISCUSSION 
The Prevalence of Therapeutic Misunderstanding and What it Means 
 Ninety-five percent of the surveyed medical students showed some level 
of TMU. But the presence or absence of TMU is not as important as the specific 
areas of misunderstanding. In the three-facet model of TMU, the area that is of 
most concern in terms is TM. In this survey, the questions were designed to be 
answered based on a typical RCT study design without respect for special cases. 
Most of the survey questions answered incorrectly fell within the TM category. 
These questions deal with mostly the design and conduct of clinical trials.  
 Specific areas of misconception were focused in the areas of 
individualization of care, such as the differences between clinical care and 
clinical research, clinician/researcher duality of role, and equipoise, for example, 
questions 17 (adjustment of treatment for best possible care), and 26 
(adjustment in medication dose as condition changes) both concern adjustments 
and changes to treatment while in a study. Though nearly all respondents 
answered the more straight forward question 12 (treatment based on medical 
needs), question 26 can be seen as the one of the most ambiguous in the survey 
The use of the word “may” could cause some confusion in the interpretation of 
the question when used in an absolute context of true or false. As there is no 
indication in the scenario preceding the survey that this would be a dose 
escalation study or a cross-over design, it should be assumed that the 
intervention would remain the same throughout the study. The survey questions 
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were not written specific enough to make the assumption that this question may 
include special cases such as discontinuation of the intervention because of an 
adverse effect. This is in contrast to the similar questions 7 or 17, which have 
more definitive wording and were answered correctly by nearly all participants. 
 The area of TE showed much better understanding. These questions were 
more focused on the risk/benefit ratios of clinical trials. Here, nearly all the 
participants answered the questions correctly, not overestimating the possible 
benefits of participating in the study. 
  In contrast between the TM and TE areas, the medical students had a 
better understanding of the ultimate goals of the research study versus 
anticipated outcomes for individual clinical trial subjects. The third facet of TMU, 
TO, was examined, but not scored with the other two facets. It was believed that 
within this population that the emotional response of participating in a RCT would 
be difficult to replicate with participants not actively participating in a RCT as the 
survey was initially designed for. The medical students did show a generally 
positive optimism towards participating in a study though. Also, consistent with 
the understanding of the risk/benefit ratio shown by the responses to the TE 
questions, the questions (6, and 14) concerning successful treatment outcomes 
had less positive optimism with many more false responses. 
 There were several characteristics that were thought to have possible 
effects on how the questionnaire was answered, among them, previous 
experience in research, especially clinical research, and previous participation in 
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a RCT. However, there were no observable, consistent trends among the various 
demographic and personal history predictors versus responses to the TMU scale. 
A larger sample size would be needed to see if any trends exist. 
 
Attitudes Towards Clinical Research and Clinical Research Ethics Education 
 A substantial number of the study participants highly agreed that 
education in clinical research and clinical research ethics is important. Previous 
work by Roberts et al showed similar results in medical students at other 
institutions.3,4,24,25 In this survey, unlike previous research which showed higher 
agreement among female medical students, a slightly larger percentage of male 
students with higher agreement to the importance of education in clinical 
research and clinical research ethics topics. Also, younger medical students were 
more likely to have higher agreement than older students. As expected, students 
with previous research experience highly agreed with the importance of 
education in these areas, however there was not a large enough sample of 
students without research experience to determine if this was a significant 
characteristic. Unexpectedly, students with previous participation in a clinical trial, 
or previous medical ethics coursework did not show higher agreement than those 
without. It was hypothesized that students with these types of past experiences 
would be more likely to agree with the importance of clinical research and clinical 
research ethics education.   
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Increasing the Focus of Clinical Research Education in the Undergraduate 
Medical Curriculum at BUSM 
 Despite study participants highly agreeing with the importance of 
education in clinical research and clinical research ethics, the study participants 
did not highly believe that there should be an increased focus on clinical research 
and research ethics education beyond what is currently in the curriculum at 
BUSM. Here male students were more likely than female students to highly 
agree that there should be an increased focus on clinical research education. 
This differs from previous studies that showed female students had higher 
agreement amount increasing education in these areas. In addition, there was 
also higher agreement in students who had previous research experience, 
especially those that had experience in clinical research. Participants in later 
stages of medical school, BUSM III or IV, showed higher agreement. In the past 
older age, or later stage of training were correlated with lower agreement to 
similar focus and changes to the curriculum, and this is consistent with the 
results in this study. This has been attributed to decrease in idealism, which is 
typically higher at the earlier ages and stages, as well as a perceived lack of 
need of further training and education as students’ progress through the 
curriculum. Unlike the previous studies, age did not seem correlated with this 
agreement, younger and older were nearly equal in their agreement towards 
increasing clinical research education. Again, students with previous experience 
participating in a clinical trial, or who had prior medical ethics coursework showed 
  34 
less agreement than those who had not A larger sample size would likely be 
needed to determine if these are true trends or aberrations of the small sample 
size. 
 
General Attitudes to Clinical Medicine versus Clinical Research Goals of Ethics 
Education 
 Medical student participants were generally more agreeable to the goals 
of ethics education in clinical medicine than clinical research. Unlike previous 
studies, there were no observable differences between male and female 
participants, and no consistent differences between age groups and training 
stage. There were some positive trends among those intending a research 
career, but not among those who had previous research experience or who had 
previously participated in a clinical trial. In terms of where students believe that 
this clinical research and research ethics education should be taught, the 
greatest area of agreement was in journal clubs and seminars. This is where 
most of the instruction in these topics currently exists. 
 
4.1 Limitations of Study 
 This study is limited by the small sample size and the distribution across 
the age groups and BUSM year. Odds ratios were not able to be calculated for 
many of the characteristics with the TMU scale because of the presence of many 
groups with zero data points, and those that were are unreliable due to small the 
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sample size. Statistical analysis of a more adequate sample size may lead to 
more obvious trends and statistical significance. Many of the statistical tests 
planned were not able to be completed because of the small sample size and 
distribution. A larger sample size would also better define the trends in the 
Attitudes Towards Clinical Research Ethics Education Survey  
 
 Reconsideration of how to interpret the score of the TMU scale may also 
be practical; eliminating the absolute nature of the score in favor of a small 
leeway of incorrect responses may be a more accurate indicator to the level of 
therapeutic misunderstanding, but may also mask the prevalence of TMU if there 
is a specific question or area that is commonly misunderstood.  As noted before, 
this is why analysis of individual questions in the TMU scale is as important if not 
more important than then absolute presence or absence of TMU. Also, 
expansion of the hypothetical scenario may also allow for some of the ambiguous 
questions to be interpreted by the survey participant more easily. A similar 
survey, with questions written more for this population of undergraduate medical 
students (or any group of biomedical students) may also be needed. The TMU 
scale was written to be used with research participants who had already gone 
through a full informed consent process for participation in a RCT, the 
assumption that medical students would be able to answer the questions base on 
previous education, or lack thereof, of basic research design and conduct may 
not be valid. No other validated tools exist to measure therapeutic 
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misunderstanding or any of its three facets, and only one other validated tool 
exists to measure therapeutic misconception itself, which was used for the basis 
of this expanded questionnaire. 
 If the TMU scale or other similar scales were to be used in the future, a re-
examination of the presentation may be warranted. Many of the questions may 
seem ambiguous to participants, in that in the real world of clinical research 
studies every study has its own protocol, potential benefits, and may not lend 
itself to absolute yes/no, true/false answers. Each clinical trial has its own 
nuances to its study design, and what may be true in one study may not be 
applicable in another. In this study, it was intended that the TMU scale would test 
the knowledge (or lack thereof) of the most basic blinded, randomized clinical 
trial design. 
 
4.2 Further Research Recommendations 
 Further research with larger sample size, as well as comparisons between 
multiple medical school programs and curricula would be necessary to define the 
true nature and extent of therapeutic misunderstanding in medical school 
students. Comparisons with other medical schools programs and curricula would 
allow researchers to find areas of the curricula that may be added too. 
Modifications to current courses may be preferable to new course additions. The 
ethics curriculum at Boston University School of Medicine has already been 
largely integrated into other coursework; further education in clinical research 
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conduct and research ethics could be integrated in the same way. For example, 
there could be increased focus on design and analysis of clinical research 
studies early on in meetings of journal clubs or in seminars dealing with the 
literature. Also, clinical rotations could include some time spent in clinics 
conducting research studies. Outside of the undergraduate medical curricula, 
there could be a push for more education in clinical research or clinical research 
ethics with the pre-medical education prior to matriculating to medical school. 
Many undergraduate programs include third or fourth year writing courses that 
focus on the student’s area of study, as opposed to the general writing courses 
that most first year undergraduates must take. In the case of pre-medical 
students (or other students going into biomedical research fields), there could be 
more focus on the literature and study design. This would complement the 
coursework in writing scientific papers. 
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5.0 CONCLUSIONS 
 Results of this pilot study indicate that as measured by the TMU Scale, 
Therapeutic Misunderstanding exists in the undergraduate medical student 
population. The absolute presence or absence of TMU is less important than the 
individual areas where the misunderstanding exists. Initial indications are that 
most of the misunderstanding is in the area of therapeutic misconception. In 
order to minimize therapeutic misunderstanding and promote the ability of 
medical students and future clinicians to understand and interpret the biomedical 
literature, give proper guidance to their patients about research participation, or 
become involved in the clinical research process, there needs to be basic 
education in clinical research and clinical research ethics. This is supported by 
the medical students themselves, however, there is disagreement as to whether 
this topic is adequately covered and where in the undergraduate medial 
curriculum it should exist.  
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APPENDIX A APPROVED INFORMED CONSENT DOCUMENT 
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APPENDIX B “THE THERAPEUTIC MISUNDERSTANDING SCALE” SURVEY 
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APPENDIX C “ATTITUDES TOWARDS CLINCIAL RESEARCH ETHICS 
EDUCATIONSURVEY” 
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APPENDIX D Data Tables 
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